An evaluation of the change in serum SCUBE-1 levels with CPAP treatment in patients with severe obstructive sleep apnea

Signal peptide CUB-EGF domain-containing protein 1 (SCUBE-1) is a cell surface protein, wherein inflammation causes an increase in serum. The aim of this study was to compare serum SCUBE-1 levels in OSA patients and to investigate the serum SCUBE-1 change with CPAP treatment. Blood samples were obta...

Full description

Saved in:
Bibliographic Details
Published in:Cranio 2022-12, Vol.ahead-of-print (ahead-of-print), p.1-7
Main Authors: Ilden, Oguzhan, Selcuk, Omer Tarik, Ellidag, Hamit Yasar, Türkoglu Selcuk, Nursel, Eyigor, Hulya, Renda, Levent, Isik, Unal Gökalp, Unlü, Hande Konsuk, Osma, Ustün, Yılmaz, Mustafa Deniz, Eren, Esin, Yilmaz, Necat
Format: Article
Language:English
Subjects:
CPAP
Obstructive sleep apnea
polysomnography
SCUBE-1
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Signal peptide CUB-EGF domain-containing protein 1 (SCUBE-1) is a cell surface protein, wherein inflammation causes an increase in serum. The aim of this study was to compare serum SCUBE-1 levels in OSA patients and to investigate the serum SCUBE-1 change with CPAP treatment. Blood samples were obtained from 61 severe OSA patients and from 25 control subjects evaluated as simple snorers. The 61 patients with severe OSA were treated with CPAP therapy and were recalled for follow up after 1 year. Evaluation was made after 1 year of CPAP therapy. Serum SCUBE-1 values were significantly higher in patients with severe OSA. The SCUBE-1 values significantly decreased after treatment with CPAP. Serum SCUBE-1 values in OSA patients showed a significant reduction in SCUBE-1 levels following 1 year of CPAP treatment.
ISSN:0886-9634
2151-0903
DOI:10.1080/08869634.2022.2145710